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Abstract
Background: Tourniquet hypertension arising from tourniquet inflation remains a primary concern to the anaesthetist. One 
drug commonly used to manage tourniquet hypertension is ketamine. No studies have examined the effect of  ketamine on tour-
niquet hypertension for a period of  more than one hour or an infusion of  the same.
Objective: To compare the effect of  an intravenous infusion of  ketamine versus placebo on tourniquet induced hypertension 
in patients undergoing upper and lower limb surgery under general anaesthesia.
Methods: Forty six adult patients scheduled for upper and lower limb surgery under general anaesthesia were randomized into 
two equal groups. The ketamine group received an intravenous bolus of  0.1mg/kg of  ketamine followed by an infusion of  
2ug/kg/min. The saline group received an intravenous bolus of  physiological saline followed by an infusion of  saline. All the 
patients were reviewed post-operatively. Data of  the baseline characteristics, haemodynamic changes, post-tourniquet pain and 
side effects were collected. If  post-tourniquet pain was present post-operatively, a visual analogue scale (VAS) was used to assess 
its severity.
Results: 46 patients successfully completed the trial. There were no significant differences between the groups for baseline 
patient demographics. The incidence of  tourniquet hypertension was higher in the saline group (26.1%) compared with ket-
amine group (4.6%) with a 95% confidence interval. The difference was shown to be statistically significant (‘P’<0.05). There 
was an increase in systolic blood pressure after 60 minutes of  tourniquet inflation in the saline group but the difference was not 
statistically significant(‘P’>0.866). There were no significant differences between the groups as regards diastolic blood pressure 
and heart rate. VAS scores did not differ between the two groups. Statistically, there was no difference found between the two 
groups. Side effects were minimal in the ketamine group whilst in the saline group, nausea and vomiting were predominant but 
were also not statistically significant.
Conclusion: Based on the results of  this study,there was a difference in the proportion of  tourniquet hypertension between 
the ketamine and saline groups for patients undergoing upper and lower limb orthopaedic surgery under general anaesthesia.
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Introduction
The use of  tourniquets dates back to early Roman times 
when various constricting bandages of  different widths, 
were used to control haemorrhage during amputation1,2. 
Tourniquets are commonly used in orthopaedic surgeries 
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to provide a bloodless operating field and good operating 
conditions. They have also been utilized in anaesthesia 
to prevent the central spread of  local anaesthetic during 
intravenous regional anaesthesia also known as a Bier’s 
block3.
The use of  tourniquets has been associated with various 
changes ranging from minor to life threatening and even 
fatal in some cases. Systemic effects are usually related 
to inflation and deflation of  the tourniquet, whereas lo-
cal effects and complications may result from either di-
rect pressure to the underlying tissues or ischemia in the 
tissues distal to the tourniquet2. The systemic effects in-
clude, increase in blood pressure and heart rate (tourni-
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quet hypertension or pain), temperature reduction in the 
non-perfused limb, production of  anaerobic metabolites 
and hypercoagulability1,2. The local effects of  tourniquet 
inflation include nerve, muscle, vascular and skin injury.
After inflation for 30-60 minutes, patients may develop 
increases in heart rate systolic and diastolic arterial blood 
pressure that persist until tourniquet deflation, a phe-
nomenon known as ‘tourniquet pain or hypertension’4,5. 
Tourniquet pain is defined as a vague, dull pain in the 
limb associated with an increase in heart rate and blood 
pressure1,4. Prolonged tourniquet inflation is associated 
with a gradual increase in arterial blood pressure. The in-
crease in blood pressure is resistant to analgesics and/ or 
an increase in the depth of  anaesthesia5,6.
The mechanisms involved in tourniquet pain are not well 
understood but have been postulated to be conducted by 
A- delta and C- fibres which are thought to mediate so-
matic pain3,8-10.
The treatment is non-specific, and various methods have 
been used to counter the effects of  tourniquet pain, these 
include intravenous bolus doses, local application, local 
anaesthesia, per oral administration, sub-cutaneous injec-
tion and regional anaesthesia, but most have been found 
to be unsatisfactory10,11,12. 
Several studies have been carried out to investigate the 
most effective agent in attenuating tourniquet induced 
hypertension and ketamine has been found to be one of  
the most effective intravenous agent through its interac-
tion with the N-methyl D-aspartate receptor8,10,13.
Ketamine use for tourniquet pain⁄ hypertension has been 
widely investigated8,10,13, 16. A study done by JW Park et al 
using 0.1mg⁄kg I.V and placebo on tourniquet induced 
hypertension during 60 minutes of  tourniquet inflation 
concluded that low dose ketamine given pre-operatively 
prevented tourniquet hypertension and no patients were 
found to have ketamine induced psychomimetic effects 
during follow-up at 1 hour and 24 hours after waking. 
His recommendations for future studies included a lon-
ger monitoring period8.
Other studies have been done using 0.15mg⁄kg and 
0.25mg⁄kg and 1mg⁄kg of  ketamine respectively13,16,17, 
however none of  these studies have had intra-operative 
monitoring of  blood pressure changes for more than 60 
minutes, therefore no conclusions can be made on the 
effect of  ketamine on tourniquet pain after 60 minutes 
of  tourniquet inflation. No published literature exists on 
ketamine infusions for the management of  tourniquet 
hypertension.
Based on these studies and the pharmacological profile 
of  ketamine, our study was designed with a belief  that an 
infusion of  ketamine would attenuate tourniquet induced 
blood pressure changes and cater for analgesic require-
ments for procedures lasting longer than 60 minutes with 
tourniquet application.
The current study thus investigated the effect of  a sub-
anaesthetic infusion of  ketamine on tourniquet induced 
blood pressure changes during general anaesthesia in pa-
tients undergoing orthopaedic surgery.
Our research question was: does an intravenous infusion 
of  ketamine compared with placebo, significantly reduce 
the incidence of  tourniquet induced hypertension in 
upper and lower limp surgery? Our null hypothesis was 
that there is no difference in blood pressure changes in 
patients receiving an intravenous infusion of  ketamine 
compared with those receiving placebo after tourniquet 
inflation.
Our primary objective was to compare the effect of  an 
intravenous infusion of  ketamine versus placebo on the 
incidence of  tourniquet induced hypertension in patients 
undergoing upper and lower limb surgery under gener-
al anaesthesia. Our secondary objectives were to assess 
heart rate changes associated with tourniquet use, assess 
efficacy of  ketamine on post-operative tourniquet pain 




The study was performed following approval from the 
Ethical and scientific Research and Ethics Committee at 
the Aga Khan University, East Africa.
This was a prospective, randomized, controlled single 
blinded trial. The study was conducted between January 
and March 2013 at the Aga Khan University hospital, 
Nairobi. Since Nairobi is a cosmopolitan city, the patients 
served by the hospital cut across most racial groups pres-
ent within the country. The study population included 
all adults of  the age between 18 and 80 years undergo-
ing elective upper and lower limb orthopaedic surgery. 
Patients  were recruited from the pre-anaesthesia clinic, 
which runs on a daily basis, wards and the day-care unit.
The sample population included adult American Society 
of  Anaesthesiologists (ASA) physical status I and II pa-
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tients undergoing elective and emergency orthopaedic 
surgery with tourniquet application under general anaes-
thesia.
All ASA I and II patients aged 18-80 years scheduled for 
orthopaedic surgery were included in this study. Reasons 
for exclusion from the study were:
1. ASA physical status III and above
2. Pregnant women
3. Patients with hypertension, ischaemic heart disease and 
diabetes mellitus
4. Patients with dementia or a history of  psychiatric ill-
ness
 
A sample size of  46 patients was sufficient to demonstrate 
a 30% difference in the mean blood pressure variations 
between the two groups at 95% confidence level and a 
power of  90%. A study done by Tsuyoshi et al showed 
the percentage of  patients who developed arterial pres-
sure increase of  more than 30% of  base line values be-
tween the ketamine group and the control group was 5% 
and 40% respectively13. We therefore hypothesized that 
there would be a 30% less incidence of  tourniquet hyper-
tension in the ketamine group as compared with placebo. 
The sample size was calculated based on research done by 
Tsuyoshi et al. The reported mean systolic blood pressure 
in the ketamine group was 118.75mmHg (sd=8.31) and 
for the control group was 126.13mmHg (sd = 6.1).
Using this information in the formula, assuming a 5% 
significance level and a power of  90%, the required sam-
ple size was 23 patients in each group and a total of  46 
patients.
The primary investigator approached prospective patients 
at the pre-anaesthetic clinic, ward and day-care unit. Pa-
tients were informed of  the nature of  the study, screened 
for eligibility and recruited if  eligible. Eligible patients 
then received written and oral explanations on the pur-
pose and nature of  the study. A participant flow diagram 
is shown in figure 1.
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A randomization schedule was computer generated by a 
biostatistician (not otherwise involved in the study) and 
the code was provided to the primary investigator. The 
primary investigator then prepared the solution according 
to the randomization code, 15 minutes before the start 
of  the procedure in the operating theatre. The solutions 
were labelled with the patients file number and initials of  
each solution to distinguish the two groups.
The randomization schedule specified the group to which 
each prospective patient was allocated upon enrolment in 
the trial.
Group 1: To receive I.V bolus of  0.1 mg/kg ketamine in 
a 10 ml syringe followed by an infusion of  2 µg/kg/min 
(ketamine group)
Group 2: To receive I.V bolus of  physiological saline in 
a 10 ml syringe followed by a continuous infusion of  the 
same in a 20 ml syringe (saline group)
 
All anaesthetists and anaesthetic assistants had prior sen-
sitization and training as regards the meaning of  the ini-
tials and management of  adverse drug reactions. All pa-
tients, surgeons and other health care personnel involved 
in patient management were blinded to the study groups.
On arrival to the operating theatre, standard monitoring 
was set up with automated non-invasive blood pressure 
measurement, electrocardiography and pulse oximetry. 
For the purpose of  this study, tourniquet hypertension 
was defined as an increase of  more than 30% in either 
systolic or diastolic blood pressure from baseline values. 
An I.V cannula was inserted and a three way tap attached. 
One port was used for the study solution and the other 
for induction of  anaesthesia.
A standardized general anaesthetic protocol consisting 
of  I.V midazolam 0.1-0.2mg/kg, I.V fentanyl 1ug/kg 
and I.V propofol 2-2.5mg/kg was used for induction of  
anaesthesia. The study drug and saline boluses were in-
travenously administered and infusions commenced re-
spectively in both groups after induction of  anaesthesia. 
I.V rocuronium 0.6mg/kg was used to facilitate endotra-
cheal intubation. Anaesthesia was maintained with O2/
AIR (1:1) in Isoflurane. Ventilation was controlled with 
a tidal volume of  8-10mls/kg and a respiratory rate of  
12-18b/min to maintain an end tidal carbondioxide con-
centration of  30-35. Anaesthesia was maintained with 
Isoflurane at 1-2%. End tidal Isoflurane concentrations 
were adjusted to keep arterial pressures and heart rate, af-
ter induction and before tourniquet inflation within 20% 
of  their pre-induction values and thereafter maintained 
steady during the study period. Paralysis was maintained 
with rocuronium 0.15mg/kg top up doses by decision of  
the anaesthetist and confirmed with a nerve stimulator.
Non-invasive arterial pressures, electrocardiography, pulse 
oximetry and capnography were monitored continuously. 
The concentration of  end tidal Isoflurane was monitored 
by an anaesthetic gas monitoring system. At tourniquet 
deflation, all anaesthetics were terminated, the study drug 
and saline infusions in both groups stopped and the tra-
chea extubated upon resumption of  spontaneous respi-
ration and after reversal of  neuromuscular blockade with 
I.V 0.05mg/kg neostigmine and I.V 0.02mg/kg atropine. 
Patients received supplemental oxygen by mask and were 
transported to the post-anaesthetic care unit (PACU).
Patients received standard intra-operative analgesia prior 
to surgical incision consisting of  i.v morphine 0.1mg/kg, 
i.v diclofenac 1mg/kg and i.v paracetamol 15mg/kg. This 
continued for a period of  72 hours post-operatively. I.V. 
fentanyl 0.1ug/kg was to be used as rescue analgesia if  
the patient’s systolic blood pressure increased to > 40% 
of  baseline in spite of  end tidal Isoflurane concentrations 
of  1MAC. I.V. esomeprazole 40mg i.v was given to all pa-
tients as anti-ulcer prophylaxis and ondansetron 0.1mg/
kg i.v was administered for opioid induced post-operative 
nausea and vomiting.
In the post-operative anaesthesia care unit, vital signs 
were recorded on arrival and a visual analogue scale score 
was taken one hour later.
Intra-operative and post-operative data was collected by 
the principal investigator or research assistant both in the 
operating theatre and PACU using the data collection 
form. The collected data was then entered by the princi-
pal investigator into an MS-Excel data base.
Data analysis was undertaken using the Analysis of  vari-
ance, ANOVA statistical software and Fisher’s exact test 
with the input of  a statistician who was involved since the 
beginning of  the proposal development. The same model 
was also used to assess the within group effect over time 
for blood pressure and heart rate. Student’s t-test was 
used to analyze normally distributed variables and Chi 
square test for categorical data. Wilcoxon Rank-sum test 
was used to analyze skewed data. All data was presented 
as mean ± standard deviation unless otherwise specified, 
and a ‘P’<0.05 was considered to be statistically signifi-
cant.
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Results
46 patients were enrolled into the study and were aged 
between 18-80 years, all undergoing elective lower and 
upper limb surgery. Their baseline characteristics are 
shown in table 1.
Table 1: Patients’ baseline characteristics 
 
  Ketamine Group Saline Group   
  Mean (SD) Mean (SD) ‘P’ 
Age (years) 49.4 (19) 44.8 (15.5) 0.376 
Height  (cm) 158.8 (9.4) 162.5 (10.8) 0.219 
Weight (Kg) 76.7 (10.7) 78.9 (13.3) 0.547 
Gender Male 10 (41.7) 13 (59.1) 0.376 
Gender Female 13(58.3) 10(40.9) 0.376 
        
  Median(IQR) Median(IQR)   
ASA 2 (1,2) 1.5 (1,2) 0.584 
        
      Abbreviations: IQR- Inter Quartile Range, ASA- American Society of Anaesthesiologist 
The two groups were similar with no statistical difference 
in their baseline characteristics. The mean age was 50 years 
in the ketamine group and 45 years in the saline group. 
The mean height was 158.8cm in the ketamine group and 
162.5cm in the saline group. There were more females in 
the ketamine group as compared with the saline group 
but the difference was not statistically significant. Their 
ASA physical status I/II distribution was 11/12 in the 
ketamine group and 11/12 in the saline group.
There were more lower-limb procedures than there were 
upper limb procedures ‘P’ > 0.05, therefore there was no 
statistical difference between the two groups as regards 
the type and site of  the surgery (table 2 and 3). 
Table 2: Surgery Site 
 









Upper limb ulna 0 (0) 3 (0) 3 (6.5) 
  radius 1 (4.2) 2 (9.1) 3 (6.5) 
  humerus 1 (4.2) 0 (0) 1 (2.2) 
  olecranon 1 (4.2) 0 (0) 1 (2.2) 
  metacarpals 0 (0) 2 (9.1) 2 (4.3) 
Lower limb femur 5 (20.8) 2 (9.1) 7 (15.2) 
  knee 7 (29.2) 6 (9.1) 13(28.3) 
  tibia 7 (29.2) 5 (22.7) 12 (26.1) 
  fibula 1 (4.2) 2 (9.1) 3 (6.5) 
  foot 0 (0) 1 (4.5) 1 (2.2) 
          
Abbreviations: FREQ- Frequency, CUM- Cumulative. Fisher's exact test    0.74   
Table 3: Type of Surgery 
 









TKR 5(25) 4(13.6) 9 (19.6) 
ORIF 15 (62.5) 13 (59.1) 28 (60.9) 
Sequestrectomy 2 (8.3) 1 (4.5) 3 (6.5) 
Reconstruction 0 (0) 1 (4.5) 1 (2.2) 
Arthroscopy 1 (4.2) 3 (13.6) 4 (8.7) 
Others 0 (0) 1 (4.5) 1 (2.2) 
        
Abbreviations: Freq- Frequency. Fisher's exact test    0.543  
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Figure 2: Incidence of tourniquet induced hypertension 
 
 
There was an increase in mean systolic blood pressure 
after 60 minutes of  tourniquet application in the saline 
group but not in the ketamine group (figure 3). The be-
tween groups test indicates that the variable group is not 
significant i.e. ‘P=0.866. The groups do not change in 
systolic blood pressure over time. The difference is there-
fore not statistically significant.
Figure 3: Change in mean systolic blood pressure over time 
 
 
      Key: Group 1- ketamine group, group 2- saline group  
      Abbreviations: SBP- Systolic blood pressure 
Figure 3: Change in mean systolic blood pressure over time 
 
 
      Key: Group 1- ketamine group, group 2- saline group  
      Abbreviations: SBP- Systolic blood pressure 
There was no difference in mean diastolic blood pressure between both groups after 60 minutes of  tourniquet ap-
plication (figure 4).
the ketamine group (26.08% versus 4.35%) and this was 
statistically significant (P= 0.02) as seen in figure 2.
A greater proportion of  patients in the saline group de-
veloped tourniquet induced hypertension compared with 
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Figure 4: Change in mean diastolic blood pressure over time 
 
 
Figure 4: Change in mean diastolic blood pressure over time 
 
 
In the ketamine group there was no significant increase in 
mean heart rate 60 minutes after tourniquet inflation but 
in the saline group there was an increase in mean heart 
rate after 60 minutes of  tourniquet inflation (figure 5). 
The between groups test indicates that the variable group 
is not significant i.e. P= 0.8449. 
Figure 5: Change in mean heart rate over time 
 
Key: Group 1- ketamine group, group 2- saline group 
Abbreviations: HR – Heart rate 
There was no difference in mean end tidal isoflurane after 
60 minutes of  tourniquet inflation in both groups (figure 
6). The between groups test indicates that the variable 
group is not significant i.e. ‘P’ =0.853. The within subject 
test indicate that there is not a significant time effect i.e. 
P= 0.693, meaning that the groups do not change in SBP 
over time. No patient experienced significant hyperten-
sion (arterial blood pressure > 40% of  baseline) during 
the observation intra-operatively. 
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Figure 6: Change in mean end tidal isoflurane over time 
 
 
The Kaplan Meier curve (figure 7) demonstrates that the 
time to onset of  hypertension was similar in both groups 
and that there was no difference in the proportion of  
hypertension after 60 minutes of  tourniquet time in both 
groups.
Figure 7: Kaplan Meier survival time to hypertension 
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The Wilcoxon rank-sum test was used to compare VAS 
scores between the two groups (table 4) and it showed 
that there was no difference between the two groups as 
regards VAS scores (P=0.546).
Table 4: VAS Scores 
 
Abbreviations: VAS- visual analogue scale. Wilcoxon rank-sum test  
  Ketamine group Saline group 
  Median (IQR) Median (IQR) 
VAS 2 (1,3) 2 (1,5) 
      
The fisher's exact test was used to compare frequency 
and differences in proportion of  side effects between the 
two groups (table 5 and 6). The difference was not statis-
tically significant, P=0.825. No patient complained about 
ketamine related psychotomimetic effects or psychologi-
cal disturbances on follow-up in the post-anaesthesia care 
unit (PACU).
Table 5: Side effects 
 
  Side Effects Ketamine group Saline group 
    Freq (%) Freq (%) 
  Yes 3 (12.5) 3 (13.6) 
  No 20 (87.5) 20 (86.4) 
        
Fisher's exact test 
 
Table 6: Types of side effects 
 
Type of S.E Ketamine group Saline group 
  Freq (%) Freq (%) 
Nausea/vomiting 2 (8.3) 3 (13.6) 
Headache 1 (4.2) 0 (0) 
Blurred vision 0 (0) 0 (0) 
Painful micturition 0 (0) 0 (0) 
Psychotomimetic effects 0 (0) 0 (0) 
      
Fisher's exact test 
 
Discussion
Tourniquet hypertension was defined as an increase of  
more than 30% in either systolic or diastolic blood pres-
sure, from baseline values. It was found that the incidence 
of  tourniquet induced blood pressure changes was 4.35% 
in the ketamine group and 26.08% in the saline group 
(figure 2), which is almost similar to previous studies 
which showed the incidence to be 28.6% in the saline 
group and 7.1% in the ketamine group, thus rejecting the 
null hypothesis at the beginning of  the study8.
The results of  this study showed that an intra-operative 
small bolus dose of  I.V ketamine followed by an infusion 
of  low dose ketamine, prevented systolic blood pressure 
increases and heart rate increase in the ketamine group 
compared with the saline group after 60 minutes of  tour-
niquet inflation in patients under general anaesthesia. The 
difference after analysis was not found to be statistically 
significant for systolic blood pressure and heart rate (Fig-
ure 3 and 5, P=0.866 and P=0.8449, respectively).The 
same was found for diastolic blood pressure P=0.578.
End tidal isoflurane concentrations did not change much 
over time from tourniquet inflation to deflation and the 
difference was not found to be statistically significant be-
tween the two groups (P=0.853).This result was similar 
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to previous studies8,13, although both studies used differ-
ent inhalational agents, namely enflurane and sevoflurane. 
Both agents do not differ much from isoflurane in terms 
of  haemodynamics although enflurane has the potential 
to cause arrhythmias as it sensitizes the myocardium to 
catecholamines.
VAS scores for post tourniquet pain did not vary much 
between both groups although higher scores were re-
ported in the saline group. Fisher’s exact test showed the 
P>0.05 which means that the difference was not statisti-
cally significant. Previous studies did not assess post tour-
niquet pain although they reported lower pain scores at 
the surgical site 24 hours after the surgery in the ketamine 
group as compared with the control group13.
A recent Cochrane review analyzed several studies with 
regard to the effectiveness of  ketamine administered 
peri-operatively for acute post-operative pain, the authors 
concluded that low dose ketamine was effective in de-
creasing morphine requirements in the first 24 hours af-
ter surgery and decreases the incidence of  post-operative 
nausea and vomiting, and adverse effects were mild or 
absent14. This offers an explanation as to the reason why 
the saline group had a higher incidence of  nausea and 
vomiting. None of  the patients in the ketamine group 
was found to have psychotomimetic reactions which are 
the most serious side effects of  ketamine probably due to 
the sub-anaesthetic doses used in this study.
The study was a single blinded randomized controlled 
trial that was adequately powered to detect the primary 
outcome. The calculation of  the power in the current 
study was based on other randomized controlled trials. 
The incidence of  tourniquet hypertension was found to 
be higher in the saline group than in the ketamine group 
concurring with other studies. This is the first study to 
use ketamine as an infusion for tourniquet induced hy-
pertension. All other studies used ketamine as an intrave-
nous bolus before tourniquet application.
 
Limitations
Our study has several limitations. Firstly, it was not dou-
ble blinded or multi-centred. Secondly the study was per-
formed on patients under general anaesthesia, therefore 
the effect of  ketamine alone, on tourniquet induced hy-
pertension and the causal relationship between tourni-
quet induced hypertension and tourniquet induced pain 
could not be evaluated. Thirdly, surgical procedures were 
not standardized therefore discrepancies in the response 
to tourniquet application could have contributed to find-
ing no differences between the two groups. Lastly, the 
depth of  anaesthesia may not have been identical among 
the patients because Bispectral index (BIS) or Electroen-
cephalogram (EEG) monitoring was not used to ensure 
similar anaesthetic depth.
Conclusion
On the basis of  the results of  this study, there was a sig-
nificant difference in the two groups when they were 
randomly assigned to a control and intervention group, 
as regards the incidence of  tourniquet hypertension. Al-
though JW Park, H Valli and Tsuyoshi7,8,13 also showed a 
difference, their study differed from ours in some import-
ant ways, namely, none of  their studies used an infusion 
of  ketamine after the initial bolus and we know from the 
pharmacology of  ketamine the duration of  analgesia is 
40 minutes if  given as an intravenous bolus dose15 and 
the studies quoted had tourniquet application times of  
60 minutes, while in our study tourniquet time was more 
than 60 minutes. Consequently we believe that our study 
mirrors clinical practice more closely and is thus applica-
ble to more clinical scenarios.
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